Elite Diagnostic Limited (JMSE: ELITE)

Market Cap	643.19M
Revenue (ttm)	821.28M
Net Income (ttm)	26.16M
Shares Out	353.40M
EPS (ttm)	0.07
PE Ratio	24.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,723
Open	n/a
Previous Close	1.710
Day's Range	1.710 - 1.810
52-Week Range	1.250 - 1.990
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Elite Diagnostic

Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. It offers magnetic resonance imaging, computed tomography scan, X-ray, ultrasound, and fluoroscopy. The company also provides radiology procedures, including angiograms, catheter insertion, aspirations and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In 2024, Elite Diagnostic's revenue was 821.28 million, an increase of 8.73% compared to the previous year's 755.33 million. Earnings were 26.16 million, an increase of 95.90%.